Ridgetech, Inc. cash flow statement RDGT

Annual Quarterly

In fiscal 2026, which ended Mar 31, 2026, Ridgetech, Inc. used $1.4 million of cash from operations, down 211.7% from the year before. It spent $449 on capital expenditures. Free cash flow was negative, at -$1.4 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
Operating
Depreciation and amortization
0
-68.0%
1
+43.9%
1
+10.1%
1
-42.9%
1
Stock-based compensation
—
—
—
10
+162.8%
—
Operating cash flow
-1
-211.7%
1
+139.5%
-3
+3.9%
-3
+39.0%
-5
Investing
Capital expenditures
0
-99.7%
0
-53.0%
0
+179.6%
0
+31.5%
0
Investing cash flow
-0
+100.0%
-18
-789.0%
-2
-545.3%
-0
-3.3%
-0
Financing
Financing cash flow
-0
-102.0%
2
-81.2%
8
+238.3%
2
-51.1%
5
Change in cash
Effect of exchange rate
1
-24.0%
1
+169.7%
-2
+40.6%
-3
-266.6%
2
Net change in cash
-1
+95.6%
-14
-1199.6%
1
+134.6%
-4
-665.1%
1
Free cash flow
-1
-227.6%
1
+131.3%
-3
-2.5%
-3
+37.9%
-5
Per share
Free cash flow per share
-19.19
-164.9%
29.56
+108.2%
-362.08
-5326.5%
-6.67
+78.8%
-31.48
Ratios
Free cash flow margin
-1.06%
0.91%
-2.81%
-2.83%
-3.33%
Capital expenditures to revenue
0.00%
0.13%
0.27%
0.10%
0.05%
Stock-based compensation to revenue
—
—
—
8.62%
—
Cash conversion
—
0.12x
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as
RDGT (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Cayman Islands
Headquarters
Hangzhou City, China
SEC filer status
Non-accelerated filer
SEC CIK
1856084
Former names
China Jo-Jo Drugstores, Inc. (until Feb 5, 2025); China Jo-Jo Drugstores Holdings, Inc. (until Jun 16, 2023)

Other Retail-Drug Stores and Proprietary Stores companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.